Tengion
TNGNQ · OTC
$0.00+$0.00 (+900.00%)TodayMarket closed ·
No price history for this range.
EPS: actual vs estimate
Beat the estimate in 7 of the last 8 quarters, by 20.3% on average
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q2 FY12 | -$1.88 | -$1.40 | +25.7% |
| Q1 FY12 | -$2.16 | -$2.10 | +2.9% |
| Q4 FY11 | -$2.47 | -$4.80 | −94.2% |
| Q3 FY11 | -$2.78 | -$0.40 | +85.6% |
| Q2 FY11 | -$2.99 | -$2.80 | +6.3% |
| Q1 FY11 | -$4.38 | -$4.10 | +6.3% |
| Q4 FY10 | -$6.28 | -$5.60 | +10.9% |
| Q3 FY10 | -$5.66 | -$5.40 | +4.7% |
Earnings calls
- Earnings call Q4 2012
- Tengion's CEO Presents at Lazard Capital Markets Healthcare Conference
- Earnings call Q3 2012
- Lazard Capital Markets 8th Annual Healthcare Conference
- UBS Investment Bank's Global Life Sciences Conference
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.